Blue Ridge Research Center

Roanoke, Virginia 24018

0 studies enrolling now · 5 studies all time

What they study most

Alzheimer's Disease, Epilepsy, Complex Partial, Migraine, Migraine, With or Without Aura, Relapsing-remitting Multiple Sclerosis

Studies at this site

• A Safety Study of Galcanezumab in Participants With Migraine, With or Without Aura — Completed
• Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo — Stopped early
• An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine — Completed
• Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis — Completed
• Dose Response Study of Zonegran in Patients With Newly Diagnosed Epilepsy — Completed